Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Diprivan
Propofol 10mg/mL
Emulsion for injection
AstraZeneca Limited
Fresenius Kabi AB, Uppsala, Sweden
Corden Pharma SpA, Milan, Italy
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Diprivan
Propofol 20mg/mL
Emulsion for injection
AstraZeneca Limited
Corden Pharma SpA, Milan, Italy
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Eylea
Aflibercept 40mg/mL
Solution for injection
Bayer New Zealand Limited
Regeneron Pharmaceuticals Inc, New York, United States of America
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Galvus Met
Metformin hydrochloride 850mg
Vildagliptin 50mg
Film coated tablet
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany
Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Tuas, Singapore
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Galvus Met
Metformin hydrochloride 1000mg
Vildagliptin 50mg
Film coated tablet
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany
Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Tuas, Singapore
|
Dated this 30th day of June 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz